510(k) K190851
K190851 is an FDA 510(k) premarket notification submitted by Sebia for the device "HYDRASHIFT 2/4 daratumumab". The FDA issued a decision of Substantially Equivalent on May 2, 2019. The device falls under product code CFF (Immunoelectrophoretic, Immunoglobulins, (G, A, M)), a Class II device regulated under 21 CFR 866.5510. Sebia has 33 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 2, 2019
- Date Received
- Apr 2, 2019
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Immunoelectrophoretic, Immunoglobulins, (G, A, M)
- Device Class
- Class II
- Regulation Number
- 866.5510
- Review Panel
- IM
- Submission Type
- 510(k)
Need the full FDA record for Sebia? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.